Drug Users and Hepatitis C

Share this

According to the CDC, new cases of HCV have increased 294% nationally from 2010 to 2015. Young people who use injection drugs have the highest rate of new cases. People who use drugs (PWUD) face barriers to care such as stigma, discriminatory insurance restrictions, lack of HCV education and insurance coverage issues. As of 2015, only three states had state laws and Medicaid policies capable of comprehensively preventing and treating HCV among PWUD. NVHR’s program supports increasing access to harm reduction services, drug treatment options and hepatitis C education and access to treatment for all PWUD.


NVHR’s work:


Featured articles/presentations

  • Novel Strategies to Enhance Testing and Linkage to HCV Care and Treatment

Video Slides